MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $48,000 | -9.4% | 743 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $53,000 | -27.4% | 743 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $73,000 | +15.9% | 743 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $63,000 | +6.8% | 743 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $59,000 | -18.1% | 743 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $72,000 | -17.2% | 743 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $87,000 | +4.8% | 743 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $83,000 | -5.7% | 743 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $88,000 | +4.8% | 743 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $84,000 | +68.0% | 743 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $50,000 | -26.5% | 743 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $68,000 | +6.2% | 743 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $64,000 | -17.9% | 743 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $78,000 | -16.1% | 743 | 0.0% | 0.01% | -16.7% |
| Q1 2019 | $93,000 | +10.7% | 743 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $84,000 | -57.6% | 743 | -19.7% | 0.01% | -50.0% |
| Q3 2018 | $198,000 | +13.1% | 925 | +48.0% | 0.01% | +9.1% |
| Q2 2018 | $175,000 | -4.9% | 625 | -68.8% | 0.01% | 0.0% |
| Q4 2017 | $184,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
| Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
| University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
| AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
| RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
| Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
| Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
| Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
| Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
| TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |